Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) "NEST-3"
Completed
Phase 3 Results N/AView Trial Locations
Recruitment
- Enrollment: 1,000
- Gender: Both
- Minimum Age: 40 Years
- Accepts Healthy Volunteers: No
- 60 locations, 10 countries
Principal Investigators
- Werner Hacke, MD PhD
Heidelberg University
- Justin Zivin, MD PhD
University of California, San Diego